At the Congress of Clinical Rheumatology East, Dr. Jason W. Busse suggested that physicians can consider cannabis before opioids for chronic pain when other options have been exhausted. He emphasized that non-opioid treatments should be optimized first, but for patients who do not respond well, a trial of oral cannabis products can be considered before opioids. Busse pointed out that while opioids and cannabis may have similar benefits for chronic pain, they are not particularly effective overall. He also mentioned that cannabis has a lower harm profile compared to opioids. Overall, he recommended considering cannabis as a therapeutic option before opioids for chronic pain management.
Source link